Based on the expression status of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), breast cancers are classified as four subtypes including Luminal A, Luminal B, HER2 and triple-negative breast cancer (TNBC) [1,2]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.